(Q33918953)

English

Treatment of murine breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor decreases the level of plasminogen activator transcripts, inhibits cell growth in vitro, and reduces tumorigenesis in vivo

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Treatment of murine breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor decreases the level of plasminogen activator transcripts, inhibits cell growth in vitro, and reduces tumorigenesis in vivo (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

based on heuristic

inferred from title

author name string

C L Chernicky

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

H Tan

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

L Yi

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

J R Loret de Mola

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

J Ilan

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

1 April 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Journal of Clinical Pathology

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

102-109

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Treatment of human breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor inhibits cell growth, suppresses tumorigenesis, alters the metastatic potential, and prolongs survival in vivo.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

The insulin-like growth factor-1 elevates urokinase-type plasminogen activator-1 in human breast cancer cells: a new avenue for breast cancer therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

The role of the IGF-I receptor in the growth and transformation of mammalian cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

Insulin-like growth factors in human breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

The insulin-like growth factor-I receptor signaling pathways are important for tumorigenesis and inhibition of apoptosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

Type I insulin-like growth factor receptor function in breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

Paracrine/autocrine regulation of breast cancer by the insulin-like growth factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

The IGF-I receptor in cell growth, transformation and apoptosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

Suppression of insulin-like growth factor type I receptor by a triple-helix strategy inhibits IGF-I transcription and tumorigenic potential of rat C6 glioblastoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

Insulin-like growth factor-I (IGF-I) receptors in breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

Biology and biochemistry of proteinases in tumor invasion.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

Differential biological significance of tissue-type and urokinase-type plasminogen activator in human breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

Cell cycle and growth control.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

Insulin-like growth factor-1 and its receptor mediate the autocrine proliferation of human ovarian carcinoma cell lines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

Growth regulation of human glioblastoma T98G cells by insulin-like growth factor-1 and its receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

Insulin-like growth factor receptor expression and function in human breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

Type 1 IGF receptor in human breast diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

5 July 2018

Inhibition of rat C6 glioblastoma tumor growth by expression of insulin-like growth factor I receptor antisense mRNA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

28 July 2018

Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

29 October 2018

Interferon gamma (IFNgamma) gene transfer of an EMT6 tumor that is poorly responsive to IFNgamma stimulation: increase in tumor immunogenicity is accompanied by induction of a mouse class II transactivator and class II MHC.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

29 October 2018

Differential regulation of astrocyte plasminogen activators by insulin-like growth factor-I and epidermal growth factor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

29 October 2018

Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

29 October 2018

Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

29 October 2018

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187158

29 October 2018

Relationship between multiple forms of plasminogen activator in human breast tumors and plasma and the presence of metastases in lymph nodes

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase-type plasminogen activator: a paracrine factor regulating the bioavailability of IGFs in PA-III cell-induced osteoblastic metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transfection of transforming growth factor-beta producing tumor EMT6 with interleukin-2 elicits tumor rejection and tumor reactive cytotoxic T-lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast and prostate cancer: an analysis of common epidemiological, genetic, and biochemical features

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of insulin-like growth factor I receptor expression in neuroblastoma cells induces the regression of established tumors in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon gamma and antisense transforming growth factor beta transgenes synergize to enhance the immunogenicity of a murine mammary carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue type plasminogen activator, but not urokinase, exerts transformation-enhancing activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A gelatin sponge model for studying tumor growth: flow cytometric analysis and quantitation of leukocytes and tumor cells in the EMT6 mouse tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase-type plasminogen activator antigen and early relapse in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T lymphocytes infiltrating sites of tumor rejection and progression display identical V beta usage but different cytotoxic activities

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth inhibition of MCF-7 breast cancer cells by stable expression of an insulin-like growth factor I receptor antisense ribonucleic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasminogen activators in nude mice xenotransplanted with human tumorigenic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase plasminogen activator induces angiogenesis and tumor vessel invasion in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/11950959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/MP.55.2.102

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

release_kbtem7wldfgwdnud7vd43sikqu

1 reference

https://api.fatcat.wiki/v0/release/kbtem7wldfgwdnud7vd43sikqu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33918953&oldid=2164783738"